arginyl-glycyl-aspartic acid has been researched along with piperidines in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
DeGrado, WF; Jackson, S; Mousa, S; Olson, RE; Rafalski, M; Rockwell, A; Roderick, J; Xue, CB | 1 |
Bednar, B; Bednar, RA; Cook, JJ; Cunningham, ME; Gould, RJ; Hartman, GD; Holahan, MA; Jumes, PA | 1 |
Breddin, HK; Graff, J; Harder, S; Hild, M; Kirchmaier, CM; Klinkhardt, U; Mahnel, R; Westrup, D | 1 |
Herbert, JM; Rescanières, O; Savi, P; Zamboni, G | 1 |
Aoki, T; Kato, M; Kuroda, S; Mihara, K; Nakamura, H; Ohkubo, M; Seki, J; Takahashi, F; Yamanaka, T | 1 |
Aitken, EW; Harper, MT; Jones, ML; Poole, AW; Williams, CM | 1 |
Hada, T; Harashima, H; Kato, A; Sakurai, Y; Yamamoto, S | 1 |
Feuerstein, G; Gerstenhaber, JA; Lelkes, PI; Marcinkiewicz, C; Sternberg, M | 1 |
8 other study(ies) available for arginyl-glycyl-aspartic acid and piperidines
Article | Year |
---|---|
Design, synthesis, and in vitro activities of benzamide-core glycoprotein IIb/IIIa antagonists: 2,3-diaminopropionic acid derivatives as surrogates of aspartic acid.
Topics: Alanine; Alkylation; Animals; Aspartic Acid; Benzamides; Benzamidines; Benzoates; Benzoic Acid; beta-Alanine; Carbamates; Esterases; Humans; Liver; Magnetic Resonance Spectroscopy; Oligopeptides; Piperazine; Piperazines; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Structure-Activity Relationship; Sulfonamides; Swine | 1997 |
Fibrinogen receptor antagonist-induced thrombocytopenia in chimpanzee and rhesus monkey associated with preexisting drug-dependent antibodies to platelet glycoprotein IIb/IIIa.
Topics: Animals; Autoantibodies; Autoimmune Diseases; Azepines; beta-Alanine; Blood Platelets; Disease Susceptibility; Dogs; Epitopes; Female; Fibrinolytic Agents; Humans; Immunoglobulin G; Macaca mulatta; Macromolecular Substances; Male; Molecular Structure; Oligopeptides; Pan troglodytes; Piperazines; Piperidines; Platelet Glycoprotein GPIIb-IIIa Complex; Primates; Protein Binding; Sulfonamides; Thrombocytopenia | 1999 |
Differential in vitro effects of the platelet glycoprotein IIb/IIIa inhibitors abixicimab or SR121566A on platelet aggregation, fibrinogen binding and platelet secretory parameters.
Topics: Adenosine Triphosphate; Adult; Antibodies, Monoclonal; Antigens, CD; Benzylamines; Binding Sites; Blood Platelets; Female; Fibrinogen; Humans; In Vitro Techniques; Male; Oligopeptides; P-Selectin; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Tetraspanin 30; Thiazoles | 2000 |
Studies on the binding of 3H-SR121566, an inhibitor of Gp IIb-IIIa activation.
Topics: Abciximab; Antibodies, Monoclonal; Benzylamines; Binding Sites; Binding, Competitive; Blood Cells; Cell Line; Endothelium, Vascular; Fibrinogen; Flow Cytometry; Humans; Immunoglobulin Fab Fragments; Oligopeptides; Organ Specificity; Piperidines; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Conformation; Proteins; Receptors, Thrombin; Thiazoles | 2001 |
Design, synthesis, and structure-activity relationships of potent GPIIb/IIIa antagonists: discovery of FK419.
Topics: Blood Coagulation; Blood Platelets; Humans; Male; Molecular Structure; Oligopeptides; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Propionates; Structure-Activity Relationship; von Willebrand Factor | 2005 |
RGD-ligand mimetic antagonists of integrin alphaIIbbeta3 paradoxically enhance GPVI-induced human platelet activation.
Topics: Benzodiazepines; Biomimetics; Blood Coagulation; Blood Platelets; Calcium Signaling; Enzyme Activation; Humans; Immunoglobulin gamma-Chains; Intracellular Signaling Peptides and Proteins; Ligands; Oligopeptides; Phosphatidylserines; Phosphorylation; Piperidines; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Protein Conformation; Protein-Tyrosine Kinases; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Secretory Vesicles; src-Family Kinases; Syk Kinase; Time Factors; Tirofiban; Tyrosine | 2010 |
Modality of tumor endothelial VEGFR2 silencing-mediated improvement in intratumoral distribution of lipid nanoparticles.
Topics: Animals; Antineoplastic Agents; Capillary Permeability; Carcinoma, Renal Cell; Cell Line, Tumor; Female; Humans; Kidney Neoplasms; Lipids; Liposomes; Male; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Nanoparticles; Oligopeptides; Particle Size; Piperidines; Polyethylene Glycols; RNA, Small Interfering; Tumor Microenvironment; Vascular Endothelial Growth Factor Receptor-2 | 2017 |
Bitistatin-functionalized fluorescent nanodiamond particles specifically bind to purified human platelet integrin receptor α
Topics: Animals; Benzodiazepines; Blood Platelets; Fibrinogen; Humans; Nanodiamonds; Peptides; Piperidines; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Rats, Inbred F344; Receptors, Fibrinogen; Snake Venoms; Thrombin; Thrombosis | 2017 |